A drug related to the class of proton pump inhibitors, most effective in reducing gastric acid secretion, was approved for the use in children.
The FDA has approved the drug for the short-term use in children ages 1 to 11, while previously the age group ranged 12-17.
The drug is available as delayed-release capsules in the United States or as delayed release tablets in Australia and Canada (containing esomeprazole magnesium) in strengths of 20 mg and 40 mg for adults; and as esomeprazole sodium for intravenous injection/infusion.
The approved doses for children are half of those approved for older children.
Nexium is produced by AstraZeneca and is said to be the third biggest selling pharmaceutical drug in the world.
Russia has been developing an energy module on the basis of the megawatt-class nuclear power plant since 2010. The spaceship needs neither sunlight nor solar batteries
There are legitimate authorities in Donetsk and Luhansk republics now, with which Russia can implement the project of the economic integration of the Donbass
Austria does not intend to expel Russian diplomats because of the spy scandal